Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynectics Regulatory News (SNX)

Share Price Information for Synectics (SNX)

Share Price is delayed by 15 minutes
Get Live Data
200.00    0.00 (0.00%)
Bid:
195.00
Ask:
205.00
Spread: 10.00 (5.128%)
Market Cap: £34.01m
SNX Live PriceLast checked at - London Stock Exchange

Intraday Synectics Share Chart

Trading Update

16 Oct 2025 07:01

RNS Number : 5649D
Synectics PLC
16 October 2025
 

This announcement contains inside information for the purpose of the assimilated Market Abuse Regulation (EU) 596/2014 as it forms part of the law of the United Kingdom by virtue of the European Union (Withdrawal) Act 2018, as amended.

16 October 2025

 

 

 

 

Synectics plc

("Synectics" of the "Company")

 

Trading Update

 

Synectics plc (AIM: SNX), a leader in advanced security and surveillance solutions, provides an update on trading for the year ending 30 November 2025 ("FY 2025, the "Period").

 

The Company is pleased to confirm that trading for FY 2025 is expected to deliver revenues of approximately £67m (FY24: £55.8m) and PBT of no less than £5.7m (excluding the share-based payment charge) (FY24: £4.7m).

 

Progress has been positive in the year to date, securing extensions and repeat orders with both new and existing long-term customers across a variety of sectors and geographies, in addition to successfully delivering a significant, non-recurring gaming contract in South-East Asia in the Period.

 

As outlined in the FY 2024 Annual Report and FY 2025 Interim Report, Synectics' refreshed growth strategy is focused on scaling the business sustainably through targeted investment in product development, and commercial and operational capabilities. The Company expects to increase investment in 2026, to support the Company's strategic growth ambitions and position Synectics to capitalise on substantial market opportunities ahead.

 

The Company continues to build a solid order book and has good visibility on its new business pipeline for FY 2026, supported by ongoing customer demand in growing markets. Recent contract wins in the renewables and decarbonisation sectors, announced today, reflect early traction from the Company's strategic initiatives to broaden its market reach and diversify its end markets.

 

With a strong balance sheet, a strengthening market position, and clear strategic priorities, the Board remains confident in Synectics' outlook and its ability to deliver long-term value creation.

 

 

For further information, please contact:

 

Synectics plc

Amanda Larnder, Chief Executive Officer

Paul Williams, Chief Financial Officer

email: info@synecticsplc.com

Tel: +44 (0) 114 280 2828

www.synecticsplc.com

 

 

Singer Capital Markets

Tel: +44 (0) 20 7496 3000

Jen Boorer / James Fischer / Patrick Weaver

Vigo Consulting  

Jeremy Garcia / Fiona Hetherington / Peter Jacob

synectics@vigoconsulting.com

Tel: +44 (0) 20 7390 0230

 

 

About Synectics plc

Synectics plc (AIM: SNX) is a leader in advanced security and surveillance solutions that help protect people, property and assets around the world.

 

It transforms customer operations by seamlessly integrating systems, technologies, and data into a unified solution-enhancing safety, improving efficiency, and enabling smarter, faster decision-making and response capabilities.

 

With its technical expertise, decades of experience, and strong partnerships, Synectics sets itself apart by delivering innovation and service that drive real value and long-term success.

 

Find out more at www.synecticsplc.com.

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFZMMGNKDGKZM
Date   Source Headline
10th Feb 20217:00 amRNSLetter of Intent and Notification of Results Date
7th Jan 20217:00 amRNSSynectics’ S-Bahn project goes live
15th Dec 20207:00 amRNSTrading Update
1st Dec 20207:00 amRNSSynectics appoints Dr Kerstin Wendt
26th Nov 20207:00 amRNSDirector/PDMR Shareholding
19th Nov 20207:36 amRNSDirector/PDMR Shareholding
18th Nov 202011:53 amRNSDirector/PDMR Shareholding
17th Nov 20207:00 amRNSContract Win
2nd Oct 202011:02 amRNSDirector/PDMR dealings
29th Sep 20207:00 amRNSTrading Update
12th Aug 20207:00 amRNSDirector/PDMR Shareholding
10th Aug 20207:00 amRNSDirectors' / PDMRs' Interests in Shares
30th Jul 20202:03 pmRNSDirector/PDMR Shareholding
28th Jul 20207:00 amRNSDirector/PDMR Shareholding
28th Jul 20207:00 amRNSContract Wins for 'next generation' Irish Buses
27th Jul 20204:40 pmRNSSecond Price Monitoring Extn
27th Jul 20204:35 pmRNSPrice Monitoring Extension
27th Jul 20207:00 amRNSHolding(s) in Company
23rd Jul 20208:22 amRNSHolding(s) in Company
14th Jul 20207:00 amRNSInterim Results
25th Jun 20209:12 amRNSHolding(s) in Company
16th Jun 20207:00 amRNSMajor Contract Win and Notice of Interim Results
22nd May 20207:00 amRNSContract Wins with Long Term Customers
23rd Apr 202011:49 amRNSResult of AGM
23rd Apr 20207:00 amRNSBusiness Update
6th Apr 202012:24 pmRNSRevised Arrangements for Annual General Meeting
2nd Apr 20209:11 amRNSDirector/PDMR Shareholding
23rd Mar 20202:28 pmRNSBusiness Update: COVID-19
23rd Mar 20201:48 pmRNSAvailability of Report and Accounts and AGM
11th Mar 20204:23 pmRNSDirector/PDMR Shareholding
11th Mar 202012:11 pmRNSHolding(s) in Company
6th Mar 20201:59 pmRNSDirector/PDMR Shareholding
25th Feb 20207:00 amRNSSettlement of Legal Claim
25th Feb 20207:00 amRNSFinal Results
11th Feb 20204:12 pmRNSHolding(s) in Company
7th Feb 20202:33 pmRNSHolding(s) in Company
7th Feb 202010:43 amRNSReplacement - Holding(s) in Company
7th Feb 20207:00 amRNSNotification of Final Results
6th Feb 20204:58 pmRNSHolding(s) in Company
30th Jan 202012:17 pmRNSReplacement - Holding(s) in Company
28th Jan 20208:58 amRNSHolding(s) in Company
23rd Jan 20209:55 amRNSDirectorate Changes
13th Dec 201912:00 pmRNSDirectorate Change
21st Nov 20198:42 amRNSChange of Registered Office
5th Nov 20198:51 amRNSHolding(s) in Company
30th Oct 201911:06 amRNSSecond Price Monitoring Extn
30th Oct 201911:00 amRNSPrice Monitoring Extension
30th Oct 20197:00 amRNSTrading Update
2nd Oct 20194:12 pmRNSDirector/PDMR Shareholding
23rd Jul 20198:31 amRNSContract Win

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.